Daniel Humiston, MD
Cardiovascular Disease · Farmington, UTNPI 1780679829
Payments from drug & device makers
Across 303 payments — averaging $1643.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$326K
- Esperion Therapeutics, Inc.$123K
- Amgen$47K
- Medtronic$353
- Boston Scientific$247
- Abbott$125
- plus $652 from 18 others
Across 2 payments — averaging $4345.19 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$9K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 12 | $326,364 |
| Esperion Therapeutics, Inc. | 208 | $123,103 |
| Amgen | 10 | $47,180 |
| Medtronic(2 entities) | 19 | $353 |
| Boston Scientific | 15 | $247 |
| Abbott | 5 | $125 |
| Actelion Pharmaceuticals US, Inc. | 8 | $108 |
| Novartis | 5 | $92 |
| Impulse Dynamics (USA) Inc. | 2 | $65 |
| Cvrx, Inc. | 1 | $49 |
| Baxter Healthcare | 1 | $44 |
| Abiomed | 1 | $36 |
| Amarin Pharma, Inc. | 2 | $34 |
| W. L. Gore & Associates, Inc. | 1 | $34 |
| Bayer | 2 | $31 |
| Lantheus Medical Imaging, Inc. | 1 | $26 |
| Regeneron Healthcare Solutions, Inc. | 2 | $25 |
| Johnson & Johnson | 2 | $24 |
| Preventice Services, LLC | 1 | $20 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Teleflex LLC | 1 | $13 |
| AstraZeneca | 1 | $13 |
| Livanova USA, Inc. | 1 | $12 |
| Terumo Medical Corporation | 1 | $11 |
How this compares
$498,025 in reported general payments places this provider in the 95th percentile of 131 cardiovascular disease providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Farmington
- Stephanie OlsenFarmington$406K
- Scott WestFarmington$140K
- Christopher KimFarmington$124K
- Daniel FronkFarmington$13K
- John RyanSalt Lake City$4.2M
- Brian WhisenantMurray$3.4M
- Jeffrey AndersonSalt Lake City$1.7M
- Divya Ratan VermaMurray$1.1M
- Robert FowlesSalt Lake City$611K
- Kia AfsharMurray$442K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.